PE Biosystems Appoints Deborah A. Smeltzer Vice President, Finance.FOSTER CITY, Calif.--(BW HealthWire)--November 18, 1999-- PE Biosystems (NYSE NYSE See: New York Stock Exchange :PEB PEB Physical Evaluation Board PEB Presidential Emergency Board PEB Post Exposure Bake PEB Professional Engineers Board (Singapore) PEB Pre-Engineered Building PEB Personal Electronic Ballot PEB Performance Evaluation Board ), a PE Corporation business, announced today that Deborah A. Smeltzer, 46, has been appointed vice president, finance, for PE Biosystems. Ms. Smeltzer assumed her new duties November 15. In her new position, Ms. Smeltzer will play a key role in PE Biosystems' business development efforts and will be responsible for identifying, analyzing, structuring and negotiating business opportunities. She also will be responsible for setting the financial strategy and business planning process for PE Biosystems. Ms. Smeltzer most recently served as chief financial officer and vice president of Genset SA, Paris, a global genomics company, where she was responsible for all phases of corporate finance activities, regulatory compliance, investor relations Investor relations The process by which the corporation communicates with its investors. , administration, program management and operations. She held previous positions as managing director of venture funds for Grotech Capital Group, Inc.; investment banker at Baker, Watts & Co.; and consultant for Porton International Ltd., a London-based biotechnology holding company. She received her bachelor's and master's degrees from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). , Irvine, in biological sciences and medical microbiology respectively. She received a master's degree in business administration from the Stanford University Graduate School of Business. She has served as a visiting investigator for the National Institutes of Health (NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. ) and supervised and performed research at the University of California, Berkeley The University of California, Berkeley is a public research university located in Berkeley, California, United States. Commonly referred to as UC Berkeley, Berkeley and Cal , School of Public Health, Naval Biosciences Laboratory, and at UC Irvine's School of Medicine, in the Department of Microbiology. "Deborah's strong academic credentials and scientific and business experience uniquely qualify her for this role," said Michael W. Hunkapiller, PhD, president, PE Biosystems, and vice president, PE Corporation. "Her diverse and responsible positions in biotechnology operations, investment banking and venture capital in the biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , healthcare and environmental technology arenas will serve PE Biosystems well." PE Corporation currently comprises two operating groups. The PE Biosystems Group (NYSE:PEB), with sales of $1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents, software and contract-related services to the life science industry and research community. PE Biosystems is headquartered in Foster City, Calif., and comprises four divisions: Applied Biosystems, PE Informatics, PerSeptive Biosystems, and Tropix. Celera Genomics Group (NYSE:CRA See Community Reinvestment Act. ), headquartered in Rockville, Md., intends to become the definitive source of genomic and related medical information. Information about the company is available on the worldwide web at www.pe-corp.com or by phoning 800.762.6923. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion